TheProfitWatch

MBRX - Moleculin Biotech, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.5 0.01 (2.21%) --- --- -0.01 (-1.15%) -0.02 (-4.14%) 0.01 (2.23%) 0.01 (1.12%) 0.01 (1.12%)

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.49
Diluted EPS:
Basic P/E:
-1.0488
Diluted P/E:
RSI(14) 1m:
0.0
VWAP:
0.51
RVol:

Events

Period Kind Movement Occurred At

Related News